Ketoprofen

BreastfeedingPediatric
  • TRADE NAMES: Alrheumat; Alrheumun; Aneol; Bi-Profenid; Gabrilen Retard; Keduril; Novo-Keto; Orudis (Sanofi-Aventis); Oruvail (Wyeth); Rhodis; Rhovail
  • INDICATIONS: Arthritis
  • CLASS: Non-steroidal anti-inflammatory (NSAID)
  • HALF-LIFE: 1.5–4 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Aspirin, Caffeine, Methotrexate, Probenecid

PREGNANCY CATEGORY: C

NSAIDs may cause an increased risk of serious cardiovascular and gastrointestinal adverse events, which can be fatal. This risk may increase with duration of use.

Our database has 70 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
NAILS.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RENAL.
RESPIRATORY.
OTHER.


Page last updated 08/02/2021

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top